Haha. Well, I think she erred grievously in her reasoning. And as a result she cost a lot of people a lot of money, and more importantly, she prevented or delayed Amarin from getting their just dues for doing a spectacular job developing a game-changing drug.
But, and I say this as an Amarin investor, my opinion is that she, like most public servants, probably took the case with the honest goal of trying to do the right thing.
News 
Market Data 
Discover 
